Drug discrimination in neurobiology (Q33748939)

29 July 2017

1 reference

title

Drug discrimination in neurobiology (English)

1 reference

29 July 2017

1 reference

Colpaert FC

1

1 reference

PubMed ID

10515310

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Pharmacology, Biochemistry and Behavior

29 July 2017

1 reference

29 July 2017

64

1 reference

29 July 2017

2

1 reference

29 July 2017

337-345

1 reference

N-methyl-D-aspartate produces discriminative stimuli in rats

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Abuse potential evaluation of inhalants

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Time-dependent generalization of morphine stimulus properties to meperidine: antagonism by naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of the vasodilator, hydralazine: Differential generalization with alpha1 and alpha2 adrenoreceptor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Investigations on drug produced and subjectively experienced discriminative stimuli. I. The fentanyl cue, a tool to investigate subjectively experience narcotic drug actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Apomorphine as a discriminative stimulus, and its antagonism by haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; Relation to some intrinsic and anticonvulsant effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of fentanyl and morphine: Tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Blockade of apomorphine's discriminative stimulus properties: relation to neuroleptic activity in neuropharmacological and biochemical assays

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Theoretical and methodological considerations on drug discrimination learning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

The narcotic discriminative stimulus complex: relation to analgesic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Fentanyl and apomorphine: asymmetrical generalization of discriminative stimulus properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Narcotic cue and narcotic state

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of narcotic analgesic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Narcotic cuing and analgesic activity of narcotic analgesics: Associative and dissociative characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Neuroleptic interference with the cocaine cue: Internal stimulus control of behavior and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Studies on the regulation of sensitivity to the narcotic cue

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Changes of sensitivity to the cuing properties of narcotic drugs as evidenced by generalization and cross-generalization experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Nociceptive stimulation prevents development of tolerance to narcotic analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Can chronic pain be suppressed despite purported tolerance to narcotic analgesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

A characterization of LSD-antagonist effects of pirenperone in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

A possible α2-adrenergic component in the in vivo activity of pirenperone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Evidence that adjuvant arthritis in the rat is associated with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Empirical evidence that the state dependence and drug discrimination paradigms can generate different outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Effects of drug-induced differences in reinforcement frequency on discriminative stimulus properties of fentanyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

5-HT1A receptor agonists: recent developments and controversial issues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

CNS depressant effects of volatile organic solvents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Structure-activity studies on amphetamine analogs using drug discrimination methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

NMDA antagonists make learning and recall state-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of muscarinic agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus effects of melatonin in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Bias of phencyclidine discrimination by the schedule of reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Receptor mediation of the stimulus properties of cholecystokinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

State-dependent learning produced by depressant and atropine-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Drug discrimination methods in human drug abuse liability evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Insulin, 2-deoxy-D-glucose, and food deprivation as discriminative stimuli in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus properties of pentylenetetrazol and bemegride: Some generalization and antagonism tests

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

The European Behavioural Pharmacology Society

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Dependence creating properties of lipotropin C-fragment (beta-endorphin): evidence for its internal control of behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

The discriminability of apsirin in arthritic and nonarthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

The discriminative stimulus properties of barbiturate stereoisomers.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Discriminative stimulus effects of pentobarbital in rhesus monkeys: tests of stimulus generalization and duration of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Sedation and the stimulus properties of antihistamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

Stimulus properties of benzodiazepines: correlations with binding affinities, therapeutic potency, and structure activity relationships (SAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900047-7

7 January 2021

10.1016/S0091-3057(99)00047-7

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10515310